152 related articles for article (PubMed ID: 38258358)
1. Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.
Choi C; Kang M; Seo SI; Suh J; Song C; Chung J; Kim SH; Park JY; Hwang EC; Jeong CW; Kwak C; Kim JK; Hong SH
J Korean Med Sci; 2024 Jan; 39(3):e11. PubMed ID: 38258358
[TBL] [Abstract][Full Text] [Related]
2. [Long-term survival analysis of 1 367 patients treated with radical nephrectomy from a single center].
Zou XP; Ning K; Zhang ZL; Zou L; Xiong LB; Peng YL; Zhou ZH; Liu HM; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):981-987. PubMed ID: 37968085
[No Abstract] [Full Text] [Related]
3. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
4. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy.
Kim SH; Park B; Hwang EC; Hong SH; Jeong CW; Kwak C; Byun SS; Chung J
Sci Rep; 2021 Feb; 11(1):3079. PubMed ID: 33542395
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
8. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
9. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
Zhao F; Liu X; Zhang C; Zhu H; Qi N
Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
[No Abstract] [Full Text] [Related]
10. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
11. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
[TBL] [Abstract][Full Text] [Related]
12. Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy.
Luo JH; Zhou FJ; Xie D; Zhang ZL; Liao B; Zhao HW; Dai YP; Chen LW; Chen W
World J Urol; 2010 Jun; 28(3):289-93. PubMed ID: 19916010
[TBL] [Abstract][Full Text] [Related]
13. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
Cerrato C; Patel D; Autorino R; Simone G; Yang B; Uzzo R; Porpiglia F; Capitanio U; Porter J; Beksac AT; Minervini A; Antonelli A; Cerruto MA; Lau C; Ashrafi A; Eun D; Mottrie A; Mir C; Meagher MF; Puri D; Nguyen M; Dhanji S; Liu F; Pandolfo SD; Kutikov A; Montorsi F; Gill IS; Sundaram C; Kaouk J; Derweesh IH
World J Urol; 2023 Mar; 41(3):747-755. PubMed ID: 36856832
[TBL] [Abstract][Full Text] [Related]
14. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
Xue W; Zhang Y; Wang H; Zhang Y; Hu X
Front Immunol; 2021; 12():778746. PubMed ID: 34917092
[TBL] [Abstract][Full Text] [Related]
16. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
17. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
Wei Y; Wang M; Jin Y; Zhou C; Lyu J
World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
19. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
20. Recurrence risk groups after nephrectomy for renal cell carcinoma.
Polanco Pujol L; Herranz Amo F; Caño Velasco J; Subirá Ríos D; Moralejo Gárate M; Hernández Cavieres J; Barbas Bernardos G; Bueno Chomón G; Rodríguez Fernández E; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):111-118. PubMed ID: 31836313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
